• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.57% Nasdaq Up2.12%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    4.35 Up 0.26(6.36%) Jun 28, 4:00PM EDT
    |After Hours : 4.35 0.00 (0.00%) Jun 28, 4:39PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 1,303   1,791   1,025   2,178  
    Cost of Revenue -   -   -   -  
    Gross Profit 1,303   1,791   1,025   2,178  
    Operating Expenses
    Research Development27,447  23,900  24,656  26,490  
    Selling General and Administrative9,307  11,076  8,488  8,184  
    Non Recurring -   -   -   -  
    Others253  253  253  254  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (35,704) (33,438) (32,372) (32,750)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,031  754  392  391  
    Earnings Before Interest And Taxes(34,673)(32,684)(31,980)(32,359)
    Interest Expense -   -   -   -  
    Income Before Tax(34,673)(32,684)(31,980)(32,359)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(34,673)(32,684)(31,980)(32,359)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (34,673) (32,684) (31,980) (32,359)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (34,673) (32,684) (31,980) (32,359)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.